Leibowitz, R L <br/><br/>
Treatment of localized prostate cancer with intermittent triple androgen blockade: preliminary results in 110 consecutive patients.  [electronic resource] 

 -  The oncologist  2001 
 - 177-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1083-7159 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.6-2-177  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood<br/>Aged<br/>Aged, 80 and over<br/>Androgen Antagonists--therapeutic use<br/>Anilides--administration & dosage<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Finasteride--administration & dosage<br/>Flutamide--administration & dosage<br/>Follow-Up Studies<br/>Gonadotropin-Releasing Hormone--administration & dosage<br/>Goserelin--administration & dosage<br/>Humans<br/>Leuprolide--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Nitriles<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Tosyl Compounds<br/>Treatment Outcome